Search

everythinglearnresearchcommunity

for

Search:↓

PRP may increase hair density but doesn't improve quality of life in breast cancer survivors with hair loss.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Reporter characteristics affect detection of hair loss from cancer therapy.

The type of tumor suppressor gene lost affects the behavior of skin cancer.

A man with myotonic dystrophy type 1 had 28 skin cancers, suggesting a link between the disease and skin cancer, emphasizing the need for sun protection and regular skin checks.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Eph/ephrin signaling is important for skin cell behavior and could be targeted to treat skin diseases.

Lower SMAD2/3 activation predicts more severe skin cancer.

Androgens increase cervical cancer risk and affect its development.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

CD34 is absent in most basal cell carcinoma cells but present in surrounding skin.

Analog 23 is a promising compound for prostate cancer treatment.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Increasing PDCD4 protein may help prevent or treat some skin cancers.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Reporter characteristics affect detection of hair loss from cancer therapy.

Improving hair health and managing conditions can enhance scalp cooling effectiveness in preventing hair loss during chemotherapy.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.